What is TVGNW's market cap?

$740.57K, based on the Nov 12 close of $0.04.

What sector is TVGNW in?

Healthcare, in the Biotechnology industry.

NASDAQ · TVGNWHealthcareBiotechnology

Tevogen Inc. Warrant (TVGNW)

$0.0412+0.49%

Close Nov 12, 2026 · split-adjusted

Nov 10, 2026$0.05▲ 9.15% in range

Nov 10, 2025Low $0.03 · High $0.09Nov 10, 2026

What changed · written from our data

As of Nov 12, 2026

Tevogen Inc. Warrant closed at $0.04 on Nov 12, up 0.49%, 52.9% below its highest close since Feb 15. Volume of 771.8K shares was 1.23× its 20-day average (close to normal).

Split-adjusted performance: -41.0% over one month, -2.6% over six months.

Short interest was 248.6K shares at the Oct 30 settlement, up 141.4% from the prior report (1.0 days to cover).

Market cap$740.6K18.0M shares

Revenue · quarter$0.00—

Diluted EPS$-1.52—

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Feb 150.03 – 0.09−52.9% from high

Volume771.8K1.23× 20-day avg

Volatility · 60d149.8%Annualised

Short % of float—1.0 days to cover

Net cash-$7.0MCash $1.1M

Next earnings—Not scheduled

Split-adjusted performance

1W −52.6%1M −41.0%3M −18.7%6M −2.6%YTD −2.4%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 138 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −24.5%, revenue growth +4.6%, net margin −228.7%, P/E 19.3×.

Short interest

Details →

Shares short248.6K+141.4% vs prior

Days to cover1.0Settled Oct 30

% of float—

Short vol. 10d9.0%of daily volume

Closest peers by size in Biotechnology

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TVGNWTevogen Inc. Warrant	$0.0412	+0.49%	−2.6%	—	—	—	$740.6K
ESLAWEstrella Immunopharma, Inc. Warrant	$0.0702	+12.32%	—	—	—	—	$155.5K	Compare
RVMDWRevolution Medicines, Inc. Warrant	$8.15	−5.78%	+45.8%	—	−206.2%	—	$90.0M	Compare

News about Tevogen Inc. Warrant

All news →

Tevogen Bio Announces 2026 Annual Meeting of StockholdersGlobeNewswire Inc. · Jul 14, 2026Neutral Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationBenzinga · May 21, 2026▲ Positive Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share UtilizationGlobeNewswire Inc. · Mar 13, 2026▲ Positive Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care PlatformGlobeNewswire Inc. · Mar 11, 2026▲ Positive Tevogen Bio Explores Buyout To Boost Generics PlatformBenzinga · Mar 6, 2026▼ Negative

Quick answers

What does Tevogen Inc. Warrant do?: Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
What is TVGNW's market cap?: $740.57K, based on the Nov 12 close of $0.04.
What sector is TVGNW in?: Healthcare, in the Biotechnology industry.

About Tevogen Inc. Warrant

Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.

HQ: Warren, NJ18 employeesListed Feb 15, 2024tevogen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology